Overcoming the Reproducibility Crisis - Results of the first Community Survey of the German National Research Data Infrastructure for Neuroscience.

Klingner, C.; Denker, M.; Grün, S.; Hanke, M.; Oeltze-Jafra, S.; Ohl, F. W.; Radny, J.; Rotter, S.; Scherberger, H.; Stein, A.; Wachtler, T.; Witte, O. W.; Ritter, P.

doi:10.1101/2022.04.07.487439

bioRxiv · 10.1101/2022.04.07.487439

Overcoming the Reproducibility Crisis - Results of the first Community Survey of the German National Research Data Infrastructure for Neuroscience.

Klingner, C.·Denker, M.·Grün, S.·Hanke, M.·Oeltze-Jafra, S.·Ohl, F. W.·Radny, J.·Rotter, S.·Scherberger, H.·Stein, A.·Wachtler, T.·Witte, O. W.·Ritter, P.

View original source ↗Export metadata ↓

Abstract

The lack of reproducibility of research results is a serious problem - known as "the reproducibility crisis". The German National Research Data Infrastructure (NFDI) initiative implemented by the German Research Foundation (DFG) aims to help overcoming this crisis by developing sustainable solutions for research data management (RDM). NFDI comprises domain specific consortia across all science disciplines. In the field of neuroscience, NFDI Neuroscience (NFDI-Neuro) contributes to the strengthening of systematic and standardized RDM in its research communities. NFDI-Neuro conducted a comprehensive survey amongst the neuroscience community to determine the current needs, challenges, and opinions with respect to RDM. The outcomes of this survey are presented here. The German neuroscience community perceives barriers with respect to RDM and data sharing mainly linked to (1) lack of data and metadata standards, (2) lack of community adopted provenance tracking methods, 3) lack of a privacy preserving research infrastructure for sensitive data (4) lack of RDM literacy and (5) lack of required time and resources for proper RDM. NFDI-Neuro aims to systematically address these barriers by leading and contributing to the development of standards, tools, and infrastructure and by providing training, education, and support, as well as additional resources for RDM to its research community. The RDM work of NFDI-Neuro is conducted in close collaboration with its partner EBRAINS AISBL, the coordinating entity of the EU Flagship Human Brain Project, and its Research Infrastructure (RI) EBRAINS with more than 5000 registered users and developers from more than 70 countries of all continents. While NFDI-Neuro aims to address the German national needs, it closely aligns with the international community and the topics of the Digital Europe Program and EU Data Spaces. Significance StatementA comprehensive survey amongst the neuroscience community in Germany determined the current needs, challenges, and opinions with respect to standardized research data management (RDM) to overcome the reproducibility crisis. Significant deficits were pointed out concerning the perceived lack of standards for data and metadata, lack of provenance tracking and versioning of data, lack of protected digital research infrastructure for sensitive data and the lack of education and resources for proper RDM. Yet, at the same time, an overwhelming majority of community members indicated that they would be willing to share their data with other researchers and are interested to increase their RDM skills. Thus, the survey results suggest that training, the provision of standards, tools, infrastructure and additional resources for RDM holds the potential to significantly facilitate reproducible research in neuroscience.

Explore related subjects

neuroscience Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Klingner, C., Denker, M., Grün, S., Hanke, M., Oeltze-Jafra, S., Ohl, F. W., Radny, J., Rotter, S., Scherberger, H., Stein, A., Wachtler, T., Witte, O. W., Ritter, P.. 2022-04-11. Overcoming the Reproducibility Crisis - Results of the first Community Survey of the German National Research Data Infrastructure for Neuroscience.. https://doi.org/10.1101/2022.04.07.487439

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗